#News: Cardiovascular Business spotlights the recent Circulation publication, “High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial” by Reddy et al. Read Michael Walter’s article: “Field Medical’s PFA system for ventricular tachycardia shows early potential.” The article reviews early feasibility findings from 26 patients treated as part of the VCAS trial. The FieldForce™ Ablation System is an investigational device and is limited by federal (United States) law to investigational use. #VT #Electrophysiology #PFA #MedTech #Epeeps #CircAHA
Early data suggeset the FieldForce Ablation System from Field Medical could represent a significant step forward in the treatment of scar-related ventricular tachycardia. #EPeeps #cardiology